Manhattan Scientifics, Inc. (MHTX)
Stock Price:
$0.0120 USD
0.0000 (0.00%)
Updated Aug 11, 2020 4:00 PM EDT - End of day
Key Info
| Market Cap |
6.69M |
| Revenue (ttm) |
97,000 |
| Net Income (ttm) |
-1.52M |
| Shares Out |
557.78M |
| EPS (ttm) |
0.00 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 11, 2020 |
| Last Price |
$0.0120 |
| Previous Close |
$0.0120 |
| Change ($) |
0.0000 |
| Change (%) |
0.00% |
| Day's Open |
0.0128 |
| Day's Range |
0.0116 - 0.0128 |
| Day's Volume |
174,393 |
| 52-Week Range |
0.0090 - 0.0200 |
More Stats
| Market Cap |
6.69M |
| Enterprise Value |
6.54M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
557.78M |
| Float |
457.75M |
| EPS (basic) |
n/a |
| EPS (diluted) |
0.00 |
| FCF / Share |
0.00 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
0.86 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
69.00 |
| PB Ratio |
76.01 |
| Revenue |
97,000 |
| Operating Income |
-976,000 |
| Net Income |
-1.52M |
| Free Cash Flow |
-319,000 |
| Net Cash |
156,000 |
| Net Cash / Share |
0.00 |
| Gross Margin |
100.00% |
| Operating Margin |
-1,006.19% |
| Profit Margin |
-1,564.90% |
| FCF Margin |
-328.87% |
| ROA |
-30.66% |
| ROE |
-131.83% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
0.25
Current: $0.0120
High
0.25
Target: 0.25
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 0.10 | - | 0.14 | 0.15 | 0.06 | 0.64 | 0.65 | 0.69 | 0.69 | 1.69 |
| Revenue Growth | - | - | -5.33% | 134.38% | -90.03% | -1.53% | -5.92% | 0.87% | -59.25% | - |
| Gross Profit | 0.10 | -0.01 | -0.05 | 0.11 | 0.06 | 0.64 | 0.65 | 0.69 | 0.58 | 1.56 |
| Operating Income | -1.03 | -1.45 | -2.28 | -6.38 | -6.25 | -3.48 | -1.81 | -1.65 | -2.17 | 0.01 |
| Net Income | -1.22 | -8.33 | 1.55 | -6.11 | 8.01 | -3.81 | -1.93 | -2.09 | -2.29 | -0.04 |
| Shares Outstanding | 549 | 534 | 534 | 535 | 522 | 486 | 461 | 450 | 426 | 402 |
| Earnings Per Share | - | -0.02 | - | -0.01 | 0.02 | -0.01 | - | - | - | - |
| Operating Cash Flow | -0.32 | -0.68 | -0.79 | -4.56 | 3.42 | -2.54 | -0.96 | -1.08 | -1.20 | 0.46 |
| Capital Expenditures | - | - | -0.01 | -0.01 | -0.26 | -0.04 | -0.18 | - | - | - |
| Free Cash Flow | -0.32 | -0.68 | -0.80 | -4.57 | 3.16 | -2.57 | -1.14 | -1.08 | -1.20 | 0.46 |
| Cash & Equivalents | 0.26 | 0.09 | 0.27 | 1.07 | 5.36 | 2.53 | 0.58 | 0.11 | 0.19 | 1.12 |
| Total Debt | 0.08 | - | - | 2.41 | 2.38 | 2.96 | 2.63 | 1.79 | 1.22 | 1.03 |
| Net Cash / Debt | 0.18 | 0.09 | 0.27 | -1.35 | 2.99 | -0.43 | -2.06 | -1.68 | -1.03 | 0.09 |
| Assets | 2.23 | 2.66 | 10.85 | 7.64 | 12.87 | 3.63 | 1.86 | 1.85 | 2.11 | 1.93 |
| Liabilities | 2.17 | 1.75 | 1.63 | 3.85 | 3.22 | 3.41 | 3.04 | 2.65 | 2.07 | 1.86 |
| Book Value | -1.01 | -0.15 | 8.16 | 2.72 | 8.59 | -0.83 | -2.24 | -0.80 | 0.04 | 0.07 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Manhattan Scientifics, Inc. |
| Country |
United States |
| Employees |
1 |
| CEO |
Emmanuel Tsoupanarias |
Stock Information
| Ticker Symbol |
MHTX |
| Stock Exchange |
US OTC |
| Sector |
Technology |
| Industry |
Diversified Electronics |
| Unique Identifier |
OTCMKTS: MHTX |
Description
Manhattan Scientifics, Inc., a technology incubator, develops and commercializes life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.